Alpine Immune Sciences logo
Alpine Immune Sciences ALPN
$ 64.97 0.0%

Quarterly report 2024-Q1
added 05-09-2024

report update icon

Alpine Immune Sciences Financial Ratios 2011-2025 | ALPN

Annual Financial Ratios Alpine Immune Sciences

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-4.7 -4.2 -8.7 -1.3 -2.5 -9.2 -1.1 -1.9 - - - -

P/S

8.9 9.0 26.1 31.5 130.6 41.5 - - - - - -

EPS

-1.7 -2.0 -1.3 -2.3 -2.6 -1.2 -2.0 -2.4 -20.3 -104.5 - -

EV (Enterprise Value)

363 M 277 M 291 M 63.4 M 91.7 M 70.2 M 15.9 M 23.4 M 16.5 M 94.3 M - -

EBITDA per Share

-1.72 -1.93 -1.35 -2.35 -2.62 -2.27 -8.2 -9.75 - - - -

EV/EBITDA

-5.5 -10.0 -1.0 -2.4 -4.7 -0.3 -0.8 - - - -

PEG

4.18 0.31 0.35 -0.1 0.02 -0.11 -0.06 0.07 - - - -

P/B

1.5 1.7 3.9 1.9 2.1 0.9 0.6 0.5 - - - -

P/CF

-6.1 -13.8 8.1 -1.5 -3.2 -4.2 -1.3 -2.3 - - - -

ROE %

-32.19 -41.63 -44.95 -142.00 -81.83 -9.86 -56.76 -27.33 - - - -

ROA %

-20.15 -19.67 -19.39 -77.37 -66.49 -9.13 -50.80 -25.96 - - - -

ROCE %

-32.41 -41.24 -46.25 -95.95 -78.35 -17.97 -57.55 -27.43 - - - -

Current Ratio

2.7 1.9 1.8 4.9 6.6 43.6 9.5 19.8 - - - -

DSO

154.1 194.6 - 143.9 122.7 27.0 - - - - - -

DIO

- - - - - - - - - - - -

DPO

- - - - - - - - - - - -

Operating Cycle

154.1 194.6 - - - - - - - - - -

Cash Conversion Cycle

154.1 194.6 - - - - - - - - - -
P/E
P/S
EV/EBITDA
PEG
P/B
P/CF
ROE %
ROA %
ROCE %
Current Ratio
DSO
DIO
DPO
202220222021202120202020201920192018201820172017201620162015201520142014201320132012201220112011240 240 160 160 80 80 0 0 -80 -80 -160 -160
Download SVG
Download PNG
Download CSV

All numbers in USD currency

Quarterly Financial Ratios Alpine Immune Sciences

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.28 - -0.24 -0.27 -0.28 - -0.42 -0.6 -0.25 - -0.55 -0.46 -0.45 - -0.28 -0.53 -0.3 - -0.62 -0.64 -0.7 - -0.88 -0.57 -0.38 - 0.2 -5.4 -3.23 -0.5 -0.61 -0.55 -0.51 -0.42 -0.39 -1.41 -1.95 -1.58 -7.68 -25.7 -27.02 - - - - - - - - - - - -

EBITDA per Share

-0.35 - - - -0.32 - -0.42 -0.53 -0.24 - -0.52 -0.44 -0.43 - -0.29 -0.51 -0.29 - -0.61 -0.64 -0.7 - -0.87 -0.6 -0.4 - -0.41 -5.31 -3.16 -503 -0.58 -0.55 -0.51 -429 -0.39 -1.4 -1.95 -1.58 K -7.53 -23.9 -27.3 K - - - - - - - - - - - -

ROE %

-27.66 -22.84 -30.14 -30.18 -40.59 -32.00 -42.98 -46.68 -53.66 -56.12 -65.99 -64.88 -55.69 -34.75 -73.68 -102.74 -126.99 -121.16 -148.39 -136.68 -114.18 -56.85 -54.17 -24.25 -11.08 -4.39 524.98 547.97 537.23 525.61 -11.63 -44.59 -36.30 -27.33 2.66 26.67 60.27 65.44 43.31 26.59 - - - - - - - - - - - - -

ROA %

-19.74 -15.14 -19.69 -19.37 -22.55 -16.15 -21.93 -23.16 -21.68 -20.87 -25.13 -23.61 -23.60 -14.99 -36.20 -53.16 -68.18 -66.02 -88.14 -89.05 -81.54 -46.20 -43.71 -19.10 -8.91 -4.07 -65.30 -70.76 -80.23 -90.55 -36.78 -40.74 -33.70 -25.96 -30.70 -33.00 -41.02 -36.11 -23.90 -14.68 - - - - - - - - - - - - -

ROCE %

-34.07 -27.44 -35.04 -33.64 -40.96 -30.63 -41.42 -44.62 -52.54 -54.96 -66.18 -66.59 -57.80 -35.86 -75.59 -104.10 -129.64 -124.03 -151.81 -139.86 -117.49 -59.17 -64.94 -42.94 -28.67 -12.91 524.09 556.01 545.11 533.33 -11.61 -45.07 -36.57 -27.43 2.65 26.80 58.93 64.10 41.97 25.12 - - - - - - - - - - - - -

Current Ratio

9.1 7.3 3.0 3.0 2.8 2.7 2.7 1.9 2.0 1.9 2.1 1.4 1.7 1.8 1.8 1.8 1.8 2.2 2.2 2.2 2.2 5.3 5.3 5.3 5.3 13.5 13.5 13.5 13.5 5.0 5.0 - - - - - - - - - - - - - - - - - - - - - -

DSO

1.4 - 2.3 5.0 5.2 - 9.3 12.5 84.1 - 242.9 287.6 - - 1260.9 315.2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

1.4 - 2.3 5.0 5.2 - 9.3 12.5 84.1 - 242.9 287.6 - - 1260.9 315.2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

1.4 - 2.3 5.0 5.2 - 9.3 12.5 84.1 - 242.9 287.6 - - 1260.9 315.2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
P/E
P/S
EPS
EV/EBITDA
PEG
P/B
P/CF
ROE %
ROA %
ROCE %
Current Ratio
DSO
DIO
DPO
202220222021202120202020201920192018201820172017201620162015201520142014201320132012201220112011240 240 160 160 80 80 0 0 -80 -80 -160 -160
Download SVG
Download PNG
Download CSV

All numbers in USD currency